Featured Products

My Quote Request

No products added yet

6505-01-344-0489

20 Products

NDC61570-0112-01

RAMIPRIL CAPSULES

NSN, MFG P/N

6505013440489

NSN

6505-01-344-0489

View More Info

NDC61570-0112-01

RAMIPRIL CAPSULES

NSN, MFG P/N

6505013440489

NSN

6505-01-344-0489

MFG

MONARCH PHARMACEUTICALS INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS RAMIPRIL ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RAMIPRIL CAPSULES 5MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CARDIAC DRUG

ALTACE

RAMIPRIL CAPSULES

NSN, MFG P/N

6505013440490

NSN

6505-01-344-0490

View More Info

ALTACE

RAMIPRIL CAPSULES

NSN, MFG P/N

6505013440490

NSN

6505-01-344-0490

MFG

MONARCH PHARMACEUTICALS INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS RAMIPRIL ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RAMIPRIL CAPSULES 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CARDIAC DRUG

NDC61570-0120-01

RAMIPRIL CAPSULES

NSN, MFG P/N

6505013440490

NSN

6505-01-344-0490

View More Info

NDC61570-0120-01

RAMIPRIL CAPSULES

NSN, MFG P/N

6505013440490

NSN

6505-01-344-0490

MFG

MONARCH PHARMACEUTICALS INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS RAMIPRIL ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RAMIPRIL CAPSULES 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CARDIAC DRUG

8104

SUNSCREEN PREPARATION

NSN, MFG P/N

6505013440495

NSN

6505-01-344-0495

View More Info

8104

SUNSCREEN PREPARATION

NSN, MFG P/N

6505013440495

NSN

6505-01-344-0495

MFG

SPORTZ BLOC INC

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: SUNSCREEN PREPARATION 5OZ BOTTLE 24S
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 OUNCES
PRIMARY CONTAINER TYPE: CONTAINER WITH FLIP-TOP CLOSURE
SPECIAL FEATURES: CONTAINS TITANIUM DIOXIDE,ZINC OXIDE,PETROLATUM,BEESWAX,HYDROGENATED CASTOR OIL AND IRON OXIDES IN SUUFFICIENT QUANTITIES TO PROVIDE A SPF RATING OF NOT LESS THAN SPF-15,PROVIDED IN A WATERPROOF OINTMENT OR PASTE BASE
TOTAL PRIMARY CONTAINER QUANTITY: 24

SPORTZ BLOC

SUNSCREEN PREPARATION

NSN, MFG P/N

6505013440495

NSN

6505-01-344-0495

View More Info

SPORTZ BLOC

SUNSCREEN PREPARATION

NSN, MFG P/N

6505013440495

NSN

6505-01-344-0495

MFG

SPORTZ BLOC INC

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: SUNSCREEN PREPARATION 5OZ BOTTLE 24S
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 OUNCES
PRIMARY CONTAINER TYPE: CONTAINER WITH FLIP-TOP CLOSURE
SPECIAL FEATURES: CONTAINS TITANIUM DIOXIDE,ZINC OXIDE,PETROLATUM,BEESWAX,HYDROGENATED CASTOR OIL AND IRON OXIDES IN SUUFFICIENT QUANTITIES TO PROVIDE A SPF RATING OF NOT LESS THAN SPF-15,PROVIDED IN A WATERPROOF OINTMENT OR PASTE BASE
TOTAL PRIMARY CONTAINER QUANTITY: 24

2G3545

TICARCILLIN AND CLAVULANIC ACID INJECTION,USP

NSN, MFG P/N

6505013441132

NSN

6505-01-344-1132

View More Info

2G3545

TICARCILLIN AND CLAVULANIC ACID INJECTION,USP

NSN, MFG P/N

6505013441132

NSN

6505-01-344-1132

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.100 GRAMS TICARCILLIN DISODIUM EQUIVALENT AND 100.000 MILLIGRAMS CLAVULANIC ACID EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TICARCILLIN AND CLAVULANIC ACID INJECTION USP STERILE 100ML 12S
III PROTECTIVE STORAGE FEATURE: FROZEN FOR PRESERVATION
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: FROZEN PREMIXED ISO-OSMOTIC IN STERILE WATER
TOTAL PRIMARY CONTAINER QUANTITY: 12

NDC00029-6571-31

TICARCILLIN AND CLAVULANIC ACID INJECTION,USP

NSN, MFG P/N

6505013441132

NSN

6505-01-344-1132

View More Info

NDC00029-6571-31

TICARCILLIN AND CLAVULANIC ACID INJECTION,USP

NSN, MFG P/N

6505013441132

NSN

6505-01-344-1132

MFG

GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.100 GRAMS TICARCILLIN DISODIUM EQUIVALENT AND 100.000 MILLIGRAMS CLAVULANIC ACID EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TICARCILLIN AND CLAVULANIC ACID INJECTION USP STERILE 100ML 12S
III PROTECTIVE STORAGE FEATURE: FROZEN FOR PRESERVATION
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: FROZEN PREMIXED ISO-OSMOTIC IN STERILE WATER
TOTAL PRIMARY CONTAINER QUANTITY: 12

TIMENTIN

TICARCILLIN AND CLAVULANIC ACID INJECTION,USP

NSN, MFG P/N

6505013441132

NSN

6505-01-344-1132

View More Info

TIMENTIN

TICARCILLIN AND CLAVULANIC ACID INJECTION,USP

NSN, MFG P/N

6505013441132

NSN

6505-01-344-1132

MFG

GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.100 GRAMS TICARCILLIN DISODIUM EQUIVALENT AND 100.000 MILLIGRAMS CLAVULANIC ACID EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TICARCILLIN AND CLAVULANIC ACID INJECTION USP STERILE 100ML 12S
III PROTECTIVE STORAGE FEATURE: FROZEN FOR PRESERVATION
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: FROZEN PREMIXED ISO-OSMOTIC IN STERILE WATER
TOTAL PRIMARY CONTAINER QUANTITY: 12

TIMENTIN INJECTION

TICARCILLIN AND CLAVULANIC ACID INJECTION,USP

NSN, MFG P/N

6505013441132

NSN

6505-01-344-1132

View More Info

TIMENTIN INJECTION

TICARCILLIN AND CLAVULANIC ACID INJECTION,USP

NSN, MFG P/N

6505013441132

NSN

6505-01-344-1132

MFG

GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.100 GRAMS TICARCILLIN DISODIUM EQUIVALENT AND 100.000 MILLIGRAMS CLAVULANIC ACID EQUIVALENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TICARCILLIN AND CLAVULANIC ACID INJECTION USP STERILE 100ML 12S
III PROTECTIVE STORAGE FEATURE: FROZEN FOR PRESERVATION
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: FROZEN PREMIXED ISO-OSMOTIC IN STERILE WATER
TOTAL PRIMARY CONTAINER QUANTITY: 12

04-1379

FILGRASTIM INJECTION

NSN, MFG P/N

6505013441136

NSN

6505-01-344-1136

View More Info

04-1379

FILGRASTIM INJECTION

NSN, MFG P/N

6505013441136

NSN

6505-01-344-1136

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 480.000 MICROGRAMS FILGRASTIM ACTIVE INGREDIENT
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 201600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FILGRASTIM INJECTION 480MCG 1.6ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1.600 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC55513-0546-10

FILGRASTIM INJECTION

NSN, MFG P/N

6505013441136

NSN

6505-01-344-1136

View More Info

NDC55513-0546-10

FILGRASTIM INJECTION

NSN, MFG P/N

6505013441136

NSN

6505-01-344-1136

MFG

AMGEN INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 480.000 MICROGRAMS FILGRASTIM ACTIVE INGREDIENT
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 201600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FILGRASTIM INJECTION 480MCG 1.6ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1.600 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 10

NEUPOGEN

FILGRASTIM INJECTION

NSN, MFG P/N

6505013441136

NSN

6505-01-344-1136

View More Info

NEUPOGEN

FILGRASTIM INJECTION

NSN, MFG P/N

6505013441136

NSN

6505-01-344-1136

MFG

AMGEN INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 480.000 MICROGRAMS FILGRASTIM ACTIVE INGREDIENT
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 201600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FILGRASTIM INJECTION 480MCG 1.6ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1.600 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC00536-3305-01

ASPIRIN TABLETS,USP

NSN, MFG P/N

6505013443989

NSN

6505-01-344-3989

View More Info

NDC00536-3305-01

ASPIRIN TABLETS,USP

NSN, MFG P/N

6505013443989

NSN

6505-01-344-3989

MFG

RUGBY GROUP INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:NONENTERIC FILM

16505

DEXAMETHASONE SODIUM PHOSPHATE INJECTION,USP

NSN, MFG P/N

6505013443990

NSN

6505-01-344-3990

View More Info

16505

DEXAMETHASONE SODIUM PHOSPHATE INJECTION,USP

NSN, MFG P/N

6505013443990

NSN

6505-01-344-3990

MFG

LYPHOMED INC DIV OF FUJISAWA USA INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS DEXAMETHASONE SODIUM PHOSPHATE EQUIVALENT PER MILLILITER AND 1.500 MILLIGRAMS SODIUM SULFITE EQUIVALENT PER MILLILITER AND 10.000 MILLIGRAMS DEXAMETHASONE PHOSPHATE EQUIVALENT
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: EACH ML. CONTAINS 0.9% BENZYL ALCOHOL; Q.S. WATER FOR INJECTION; MADE ISOTONIC WITH SODIUM CITRATE
TOTAL PRIMARY CONTAINER QUANTITY: 25

NDC00469-1650-20

DEXAMETHASONE SODIUM PHOSPHATE INJECTION,USP

NSN, MFG P/N

6505013443990

NSN

6505-01-344-3990

View More Info

NDC00469-1650-20

DEXAMETHASONE SODIUM PHOSPHATE INJECTION,USP

NSN, MFG P/N

6505013443990

NSN

6505-01-344-3990

MFG

LYPHOMED INC DIV OF FUJISAWA USA INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS DEXAMETHASONE SODIUM PHOSPHATE EQUIVALENT PER MILLILITER AND 1.500 MILLIGRAMS SODIUM SULFITE EQUIVALENT PER MILLILITER AND 10.000 MILLIGRAMS DEXAMETHASONE PHOSPHATE EQUIVALENT
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: EACH ML. CONTAINS 0.9% BENZYL ALCOHOL; Q.S. WATER FOR INJECTION; MADE ISOTONIC WITH SODIUM CITRATE
TOTAL PRIMARY CONTAINER QUANTITY: 25

F91G080

MAGNESIUM CHLORIDE DELAYED-RELEASE TABLETS

NSN, MFG P/N

6505013444054

NSN

6505-01-344-4054

View More Info

F91G080

MAGNESIUM CHLORIDE DELAYED-RELEASE TABLETS

NSN, MFG P/N

6505013444054

NSN

6505-01-344-4054

MFG

AIR FORCE MEDICAL LOGISTICS OFFICE

Description

COATING FEATURE: FILM, ENTERIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAGNESIUM CHLORIDE DELAYED-RELEASE TABLETS 64MG 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 60 MG MAGNESIUM CHLORIDE ACTIVE INGREDIENT

NDC00025-4301-60

MAGNESIUM CHLORIDE DELAYED-RELEASE TABLETS

NSN, MFG P/N

6505013444054

NSN

6505-01-344-4054

View More Info

NDC00025-4301-60

MAGNESIUM CHLORIDE DELAYED-RELEASE TABLETS

NSN, MFG P/N

6505013444054

NSN

6505-01-344-4054

MFG

SANOFI-SYNTHELABO INC

Description

COATING FEATURE: FILM, ENTERIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAGNESIUM CHLORIDE DELAYED-RELEASE TABLETS 64MG 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 60 MG MAGNESIUM CHLORIDE ACTIVE INGREDIENT

NDC54092-0027-60

MAGNESIUM CHLORIDE DELAYED-RELEASE TABLETS

NSN, MFG P/N

6505013444054

NSN

6505-01-344-4054

View More Info

NDC54092-0027-60

MAGNESIUM CHLORIDE DELAYED-RELEASE TABLETS

NSN, MFG P/N

6505013444054

NSN

6505-01-344-4054

MFG

MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS

Description

COATING FEATURE: FILM, ENTERIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAGNESIUM CHLORIDE DELAYED-RELEASE TABLETS 64MG 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 60 MG MAGNESIUM CHLORIDE ACTIVE INGREDIENT

NDC00182-1760-01

PROPRANOLOL HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505013444710

NSN

6505-01-344-4710

View More Info

NDC00182-1760-01

PROPRANOLOL HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505013444710

NSN

6505-01-344-4710

MFG

GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS PROPRANOLOL HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

04-0017

PERITONEAL DIALYSIS SOLUTION

NSN, MFG P/N

6505013444711

NSN

6505-01-344-4711

View More Info

04-0017

PERITONEAL DIALYSIS SOLUTION

NSN, MFG P/N

6505013444711

NSN

6505-01-344-4711

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 96.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 1.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND MILLIEQUIVALENTS LACTATE ION PER LITER 40.000 AND
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 403600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PERITONEAL DIALYSIS SOULUTION 346 MOSM/L 2000 ML (6) BAGS PER CASE
PRIMARY CONTAINER CONTENT QUANTITY: 2000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: 6 BAGS PER CASE; MUST BE USED WITH NDC 6515-01-328-8648, ADMINISTRATION SET, PERITONEAL DIALYSIS AND MINICAP DISCONNECT WITH NSN 6515-01-516-8776, STORE AT ROOM TEMPERATURE 68-77 DEG F (20-25 DEG C)
~1: MILLIEQUIVALENTS MAGNESIUM ION PER LITER 0.500